For those who are interested in learning more about the issues to be addressed at the conference, the following articles are suggested.
- David, Eric, Amit Mehta, Troy Norris, Navjot Singh, and Tony Tramontin. 2010. “New frontiers in pharma R&D investment.” McKinsey Quarterly.
- Fernandez, Jose Maria., Roger M. Stein, and Andrew W. Lo. 2012. “Commercializing biomedical research through securitization techniques.” Nature Biotechnology 30: 964-975.
- Huggett, Brady. 2012. “Biotech’s wellspring: a survey of the health of the private sector.” Nature Biotechnology 30: 395-400.
- Milken Insitute and FasterCures. 2012. “Fixes in Financing: Financial Innovations for Translational Research.” A Financial Innovations Lab Report.
- Yang, Walter. 2012. “2011–Big biotechs gorge on debt.” Nature Biotechnology 30: 127.